QLSCX
Price
$26.45
Change
-$0.00 (-0.00%)
Updated
Sep 18 closing price
VSCIX
Price
$111.88
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
Ad is loading...

QLSCX vs VSCIX

Header iconQLSCX vs VSCIX Comparison
Open Charts QLSCX vs VSCIXBanner chart's image
Federated Hermes MDT Small Cap Core R6
Price$26.45
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Index I
Price$111.88
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
QLSCX vs VSCIX Comparison Chart
Loading...
VS
QLSCX vs. VSCIX commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QLSCX is a Buy and VSCIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 149B vs. QLSCX (1.37B). VSCIX pays higher dividends than QLSCX: VSCIX (1.43) vs QLSCX (0.30). QLSCX was incepted earlier than VSCIX: QLSCX (8 years) vs VSCIX (27 years). QLSCX is a more actively managed with annual turnover of: 128.00 vs. VSCIX (12.00). QLSCX has a lower initial minimum investment than VSCIX: QLSCX (0) vs VSCIX (5000000). QLSCX annual gain was more profitable for investors over the last year : 28.61 vs. VSCIX (20.29). VSCIX return over 5 years is better than : 51.42 vs. QLSCX (41.46).
QLSCXVSCIXQLSCX / VSCIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years27 years-
Gain YTD12.8419.674133%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.37B149B1%
Annual Yield % from dividends0.301.4321%
Returns for 1 year28.6120.29141%
Returns for 3 years-6.815.66-120%
Returns for 5 years41.4651.4281%
Returns for 10 yearsN/A114.04-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AVNT47.600.50
+1.06%
Avient Corp
AFCG10.620.08
+0.76%
AFC Gamma
BBD2.800.01
+0.36%
Banco Bradesco SA
BTAI0.63-0.01
-1.50%
BioXcel Therapeutics
LAB2.00-0.09
-4.31%
Standard BioTools